Alicia obtained her PhD degree in neuropharmacology and afterwards continued her post-doctoral career in pre-clinical research at the Cardiology Unit at Vall d’Hebron and Neurobiology department at the University of Barcelona.
Alicia started her career in clinical research at Bayer. From there she moved to positions of increased responsibilities in different biopharma companies (Almirall, Jassen Pharmaceutica, Merck Serono and Novartis) where she was involved in the management of key clinical trials in the development of drugs such as aclidinium (COPD), bortezomib (multiple myeloma). She also played a key role in the global team spearheading the development of safinamide (Parkinson’s disease). Main therapeutic areas of expertise include Oncology, Neurology and Respiratory, as well as Vaccines and Fertility.
Alicia has broad experience encompassing the entire spectrum of drug development from early clinical stages to the latest phase, including launch and phase IV clinical studies. She has the proven ability to lead large, multinational and cross-functional teams.
She enjoys working in an international, diverse and dynamic environment and is passionate to take on new challenges and keep learning.
With a Master’s Degree in Biomedical Sciences and a Postgraduate degree in Clinical Biochemistry from the University of Bari (Italy), Andrea confirmed his desire to deepen his knowledge in the field of Molecular Oncology and Translational Medicine. In 2007, Andrea started his work experience as Research Fellow at the National Cancer Institute of Bari (Italy), where his research activity was mainly focused on the identification of new potential molecular biomarkers of ´prognosis and response´ to treatment in breast cancer and colorectal tumors.
In 2013, Andrea decided to give an international scope to his research training, moving to Barcelona, Spain under a European Marie Skłodowska-Curie fellowship. After an experience as a Visiting Research Fellow at the Medical University of Vienna (Austria), Andrea obtained his Ph.D. in Biomedicine from the University of Barcelona with a translational-minded thesis about the role of TGF-β on “stemness” properties in human hepatocellular carcinoma.
As part of his second Master’s Degree in Management and Monitoring of Clinical Trials from the CEU Cardenal Herrera University of Valencia, Andrea joined MedSIR in April 2017 as a Project Management Assistant. His passion for Health & Life Sciences, his strong experience in basic/translational research in Oncology with a proven publication track record, has played a key role in Andrea’s advancement to Scientific Development Manager.
After obtaining a Bachelor´s degree in Biology in 2002 from the Universidad Nacional de La Plata, Argentina, Leonardo moved to Spain to complete a Master’s Degree in Biochemistry and Biotechnology at the Francisco de Vitoria Universidad de Madrid. Later obtaining his PhD in Virology at the Universitat Pompeu Fabra in Barcelona. Over the following 5 years, Leo continued his career as a Post-doc in the field of Fanconi Anemia (FA) at the Universitat Autonoma de Barcelona, where his work focused on exploring the FA/BRCA pathway as a new target for anti-tumoral therapies.
Leo has extensive experience as a Biomedical researcher. Over the course of his career, he has consistently shown the ability to produce and deliver good-quality experimental results suitable for publication in top-level international peer-reviewed journals. Additionally, his knowledge of scientific methodology combined with statistical know-how makes him a valuable asset to collect and analyze complex datasets.
As part of the Master’s Degree from the COMB (Official College of Physicians of Barcelona), Leo joined MedSIR in June 2016 as Project Management Assistant, getting involved and collaborating in many different projects, and he is currently developing his growth in the company as Digital Project Manager.
Data Analytics Manager
Crina has a PhD in Biotechnology and more than 5 years of experience in managing scientific research projects. She has a strong scientific background, broad array of laboratory techniques, and expertise in genetics, microbiology, biochemistry, cellular and molecular biology. During her work experience, she has had successful collaborations with biotechnology companies and international research groups, and developed a strong interest in working in teams with diverse scientific backgrounds. As a Project Coordinator at The Paper Mill company, she organized several workshops and science outreach activities, gaining strong knowledge of the Spanish research context and familiarity with communication and management in a scientific setting.
As part of the Master’s program in Clinical Trial Monitoring from IUSC Barcelona, Crina joined MedSIR in July 2018 as an Assistant to the International Trial Lead Trainee. In October 2018, she initiated her career in clinical research as a Clinical Research Associate of the PHERGain phase II international trial. Her thirst for knowledge made her accept new challenges and develop her growth in MedSIR, and in January 2020, she started her adventure as both Lead Clinical Research Associate in the PHERGain study and Scientific Specialist. Currently, she is a member of the Operations and Scientific Departments.
Crina is fluent in Romanian, Spanish, Catalan and English.
Silvia holds a Bachelor of Science in Biology and a PhD in Biomedicine from the University of Barcelona. Her research focused on the identification of new drugs and biomarkers for the treatment of diabetes (type 1 and type 2), obesity and metabolic syndrome. She is co-author of several scientific publications and patents.
Silvia joined Genmedica Therapeutics, a biotech focused in the identification of new treatments for type 2 diabetes where she covered the drug development process from drug discovery and preclinical studies up to clinical phases of the company’s lead candidate. She was is in charge of overseeing the development processes of drug candidates, interacting with CROs and managing the R&D&I activities of the company. In 2019, Silvia moved on to work at Innoqua Toxicology Consultants.
Silvia joined Medsir in June 2019 as an Assistant to the International Trial Lead Trainee as part of the master’s program in Clinical Trial Monitoring from UNIR. In February 2020, she moved on to clinical research at Medsir as a Site Manager and Data Management Specialist.
Silvia loves figure skating and cinema. She speaks fluently Spanish, Catalan and English, and knows some German.
Scientific Communications Specialist
Mario educational background includes a Bachelor’s degree in Biology from the University of Naples (Italy) and a PhD in Oncology and Genetics from the University of Siena (Italy).
Native to a small island in the Bay of Naples (Procida), his passion for science led him to move as a postdoctoral fellow at the National Cancer Institute/National Institutes of Health in Bethesda, MD, USA during four years. This experience has actually strengthened his own research competency and provide him with a strong scientific background.
Ten years ago, Mario arrived in Barcelona to join the Molecular and Translational Oncology laboratory at Hospital Clínic. Over this time, he worked mainly on the cross talk between breast cancer and the neuroendocrine system. To this respect, he identified 6 neurogenes that are differentially expressed among breast cancer subtypes and whose expression correlates with prognosis.
Mario is author of several articles published in peer-reviewed journals.
To continue his professional growth and pursue his passion for science Mario joined MedSIR in June 2020 as International Scientific Communication Specialist.
Mario speaks Italian, Spanish, English, and Catalan fluently.